Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Divergent protein kinase domain 1C (DIPK1C) is a protein encoded by the human FAM69C (C18orf51) gene[3]. It belongs to the FAM69 family of cysteine-rich domain proteins. The detailed biological role and molecular activity of DIPK1C remain unclear, and the gene/protein has not been systematically linked to major signaling pathways, receptor activities, or therapeutic relevance in current biomedical literature[3]. DIPK1C is not presently classified as a recognized therapeutic target, and no pharmacological agents, mechanisms of action, or safety data are available. Aliases listed for the gene and protein reflect nomenclature used in various genomics and protein databases, but functional annotation is sparse. The existence of an alternative name referencing "familial non-conventional Alzheimer's dementia" (FNCAD) suggests a possible research connection, but this is not substantiated in authoritative sources and should be interpreted with caution pending further peer-reviewed research[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Divergent protein kinase domain 1C (DIPK1C).